Free shipping on all orders over $ 500

Zagotenemab

Cat. No. M24875

All AbMole products are for research use only, cannot be used for human consumption.

Zagotenemab Structure
Synonym:

LY33003560

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Zagotenemab (LY3303560) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research.

Chemical Information
CAS Number 2019133-28-7
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Morteza Abyadeh, et al. Aging Dis. Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease

[2] Miguel Vaz, et al. Eur J Pharmacol. Alzheimer's disease: Recent treatment strategies

Related Microtubule Products
CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

Paclitaxel-d5

Paclitaxel-d5

  Catalog
Abmole Inhibitor Catalog




Keywords: Zagotenemab, LY33003560 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.